Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10982670 | Journal of Hospital Infection | 2018 | 11 Pages |
Abstract
Effective multi-modal HH interventions are likely to be cost-effective due to preventing MRSA-BSI alone in ICU settings in middle-income countries where baseline compliance is typically low. Where compliance is higher, the cost-effectiveness of interventions to improve it further will depend on the impact on hospital-acquired infections other than MRSA-BSI.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
N. Luangasanatip, M. Hongsuwan, Y. Lubell, D. Limmathurotsakul, P. Srisamang, N.P.J. Day, N. Graves, B.S. Cooper,